Arca
Skip to content
Tools
Tools

Cutaneous lupus erythematosus

Drug research and approvals for cutaneous lupus erythematosus: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.

As of Nov 22, 2026, 22 studies of cutaneous lupus erythematosus are recruiting on ClinicalTrials.gov, and Health Canada has authorized 3 drug trials for it since 2013.

  • Recruiting worldwide: 22
  • Trials authorized in Canada: 3
  • FDA orphan approvals: 0
  • EU medicines: 0

Recruiting now

Newest posted first, of 22 recruiting on ClinicalTrials.gov ↗

Drug pipeline

Each drug at the furthest stage it has reached for this condition, from ChEMBL's drug indications

Phase 3 3

Phase 2 12 of 14

Phase 1 or earlier 7

How its trials ended

47 ClinicalTrials.gov studies of the condition, classified by TrialPanorama, partly automatically, so some labels are wrong

Of the 12 whose ending is known, 17% met their primary endpoint, 8% missed it and 75% stopped early.

  • Completed, result not reported2349%
  • Ongoing1021%
  • Stopped: other or unclear49%
  • Stopped: enrollment or feasibility36%
  • Met its primary endpoint24%
  • Status unknown24%
  • Missed its primary endpoint12%
  • Stopped: sponsor or business decision12%
  • Stopped: funding12%

Trials authorized in Canada

Newest first; search them all in Canada trials
Jun 25, 2025A phase 2b, randomized, double-blind, placebo-controlled study to assess the safety, tolerability, and efficacy of IMVT-1402 in participants with active…IMVT-1402Immunovant Sciences GmbHClosed
Sep 14, 2022A 2-part seamless part a (phase 2)/part b (phase 3) randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficacy and safety of…BIIB059BiogenOngoing
Feb 12, 2021A randomized, double-blind, placebo controlled, proof of concept study assessing the efficacy and safety of the RIPK1-inhibitor SAR443122 in patients with…Eclitasertib (SAR443122)Sanofi-Aventis Canada IncOngoing

Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.